Proteomics approach for biomarker discovery in Kawasaki disease.

Efforts to improve the clinical and diagnostic evaluation of KD have focused on general markers of inflammation which are not specific for KD. Identification of a proteomic based biomarker can reliably and specifically differentiate KD from other disease and would help in the prompt diagnosis. Comprehensive analysis of serum proteome of patients with KD may be helpful in identifying candidate protein biomarkers.